Primary esophageal T cell lymphoma.
A 60 year-old woman with primary esophageal T-cell lymphoma in clinical stage I(E)B is presented. Immunohistologic examination showed tumor cells to be positive for anti-LCA, anti-UCHL-1, anti-MT-1, anti-CD3 antibodies, and negative for anti-L26 antibody. Disappearance of dysphagia and improvement in esophageal findings were noted after 65 Gy of irradiation, and biopsy specimens from the esophagus revealed no malignancy. Primary esophageal lymphoma is extremely rare, and this T-cell lymphoma is only the fourth case reported in the literature.
Fujisawa
S
S
First Department of Internal Medicine, Urafune Hospital, Yokohama City University School of Medicine, Kanagawa, Japan.
Motomura
S
S
Fujimaki
K
K
Tanabe
J
J
Tomita
N
N
Hara
M
M
Mohri
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001466:Barium Sulfate; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004108:Dilatation, Pathologic / Q000150:complications / Q000000981:diagnostic imaging; D004317:Doxorubicin / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
D001466:Barium Sulfate; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone